5.23 A 12-MONTH PROSPECTIVE FOLLOW-UP STUDY OF A NAÏVE PEDIATRIC POPULATION TREATED WITH ANTIPSYCHOTICS (ETAPE STUDY): INCIDENCE RATE OF ADVERSE EVENTS IN FRANCE